Verubecestat is an oral BACE-1 inhibitor that reduces the Aβ level in the cerebrospinal fluid of patients with Alzheimer’s disease. Authors conducted a randomized, double-blind, placebo-controlled, 78-week trial to evaluate verubecestat at doses of 12 mg and 40 mg per… Continue Reading →
The Japanese Association on Sarcopenia and Frailty systematically reviewed all the papers related to clinical questions on the definition, epidemiology, prevention and intervention of sarcopenia and provided the evidence level and recommendations. This is the first clinical guidelines for sarcopenia… Continue Reading →
Care Weekly is the official journal of Caring and Ageing Re-imagined for Europe (CARE), an EIT Health Campus activity Care Weekly represents a departure from traditional communication channels serving the various challenges facing a global aging population. Personalized medicine, precision medicine, person-centered… Continue Reading →
© 2025 Aging-news